Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Unknown × Advanced Tumors × Clear all

Phase

Phase 1 3 Phase 1/2 1

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 71 Breast Neoplasms 63 Neoplasms 61 Leukemia, Myeloid, Acute 61 Multiple Myeloma 51 Lymphoma 47 Colorectal Neoplasms 47 Stomach Neoplasms 44 Recurrence 43 Carcinoma, Hepatocellular 43 Pancreatic Neoplasms 39 Neoplasm Metastasis 39 Melanoma 34 Prostatic Neoplasms 33 Leukemia 30 Lymphoma, Non-Hodgkin 28 Lymphoma, B-Cell 27 Lung Neoplasms 27 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Ovarian Neoplasms 23 Glioblastoma 23 Lymphoma, Large B-Cell, Diffuse 21 Esophageal Neoplasms 21 Myelodysplastic Syndromes 19 Leukemia, Lymphocytic, Chronic, B-Cell 19 Hematologic Neoplasms 19 Colonic Neoplasms 19 Carcinoma, Renal Cell 19 Head and Neck Neoplasms 18 Lymphoma, Mantle-Cell 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05867771 2023-05-22

A Study of PM1022 in Patients With Advanced Tumors

Biotheus Inc.

Phase 1/2 Unknown

Advanced Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡